Skip to main content
Premium Trial:

Request an Annual Quote

Genset SVP Marc Vasseur Takes Helm As CEO

NEW YORK, May 16-Genset co-founder Marc Vasseur will take the helm of the company as chief executive officer and chair of the board, the company said today.


Vasseur replaces pharma veteran Andre Pernet, 56, who recently resigned after serving less than two years as CEO.


Vasseur, 52, helped found the company in 1989. A molecular biologist by training, he served as the company's director and chief biology officer until July 2000. He left Genset to launch and head up an Institut Pasteur spin-off called Pasteur-Mediavita, returning to the company in March 2002 as senior vice president.


In March, Genset Chief Financial Officer John Varian left the firm for personal reasons.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.